Thompson Davis & Co Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SONN
Sonnet BioTherapeutics
SONN
|
+$1.18M |
| 2 |
GE Aerospace
GE
|
+$582K |
| 3 |
CBM
Cambrex Corporation
CBM
|
+$524K |
| 4 |
WFM
Whole Foods Market Inc
WFM
|
+$467K |
| 5 |
Consumer Portfolio Services
CPSS
|
+$463K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$2M |
| 2 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$1.23M |
| 3 |
iShares Micro-Cap ETF
IWC
|
+$1.17M |
| 4 |
Pfizer
PFE
|
+$1.1M |
| 5 |
Vanguard Large-Cap ETF
VV
|
+$957K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.2% |
| 2 | Real Estate | 11.29% |
| 3 | Healthcare | 10.98% |
| 4 | Industrials | 10.7% |
| 5 | Financials | 10.06% |
Similar funds
Thompson Davis & Co's Q3 2015 Portfolio in Review
As of Q3 2015, Thompson Davis & Co held 1,384 positions worth $71.5M, down 18% from $86.7M the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Thompson Davis & Co withdrew a net $7.59M in Q3 2015, closing 228 positions and reducing 364 holdings. Its most notable exit was TRADE STREET RESIDENTIAL, INC. COMMON STOCK, an estimated $536K position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Real Estate and Healthcare.
Against the trend, Thompson Davis & Co opened a new position in Sonnet BioTherapeutics worth $396K.
- Thompson Davis & Co's largest Q3 2015 buy was Sonnet BioTherapeutics: 1 share worth $396K.
- Thompson Davis & Co added most to GE Aerospace in Q3 2015, an estimated $582K increase.
- Thompson Davis & Co's biggest Q3 2015 reduction was iShares Russell 2000 ETF, cutting an estimated $2M.
- Thompson Davis & Co fully exited TRADE STREET RESIDENTIAL, INC. COMMON STOCK in Q3 2015, selling an estimated $536K.
- Thompson Davis & Co's ten largest holdings make up 21% of its $71.5M portfolio in Q3 2015.
- Thompson Davis & Co opened 165 new positions and closed 228 in Q3 2015.
- Thompson Davis & Co's portfolio value fell 18% quarter-over-quarter to $71.5M.
Based on Thompson Davis & Co's 13F filing for Q3 2015, filed 30 Oct 2015.